A study published in Circulation showed that the Apple Watch’s ECG detected some arrhythmias other than atrial fibrillation. The device is currently cleared to take ECGs and general irregular pulse alerts, which could indicate potential cases of atrial fibrillation.
AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can lead to QT prolongation, which can increase the risk of certain arrhythmias.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Fitbit launched a large-scale study to validate the use of its technology to detect atrial fibrillation. The company plans to enroll hundreds of thousands of people into the virtual study.
In a newly published study, the researchers reported that their new digital approach yielded more accurate predictions of future arrhythmic events than current blood pumping measurements.
With the recent development of leadless pacemakers, there is optimism that complication rates may be reduced in patients with implanted pacemakers.
Despite all our tricks of medical deduction, sometimes a death can just be left unexplained: No heart attack, no stroke, no slip of a cyanide pill…The post-mortem yields nothing, and families are left without closure. Researchers over at Scripps Translational Science Institute in San Diego, led by renowned cardiologist and geneticist Eric Topol, have begun a study to help families […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.